J. T. Wright Jr, G. Bakris, T. Greene, L. Y. Agodoa, L. J. Appel, J. Charleston, D. Cheek, J. G. Douglas-Baltimore, J. Gassman, R. Glassock, L. Hebert, K. Jamerson, J. Lewis, R. A. Phillips, R. D. Toto, J. P. Middleton, S. G. Rostand and African American Study of Kidney Disease and Hypertension Study Group, “Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results from the AASK Trial,” Journal of the American Medical Association, Vol. 288, No. 19, 2002, pp. 2421-2431. doi:10.1001/jama.288.19.2421

has been cited by the following article:

• TITLE: Antihypertensive Therapy in Non-Diabetic Chronic Kidney Disease Associated with Proteinuria in Adults

  AUTHORS: Khawar Maqsood, Adeel Siddiqui, Geoffrey Teehan

  KEYWORDS: Hypertension; Proteinuria; Chronic Kidney Disease

  JOURNAL NAME: Open Journal of Nephrology, Vol.3 No.3, September 9, 2013

  ABSTRACT: Controlling blood pressure and reducing proteinuria are common goals in Chronic Kidney Disease associated with hypertension and proteinuria and lead to fewer cardiovascular outcomes. This review summarizes the available literature.